How a Prescription Put a Child 'Presently at Risk of Sudden Death
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
How a Prescription Put a Child 'Presently at Risk of Sudden Death
-
ナレーター：
-
著者：
概要
Fear that a single prescription could tip a child into "sudden death" - and that the clinic that wrote it kept operating - is the chilling fact at the center of this episode. We trace how a telemedicine service prescribing hormones to minors grew from a claimed "provider of last resort" into a practice entangled in suspensions, tribunal findings, and an offshore ownership swap that left oversight trailing behind. How did a decade of warnings and two removals from the medical register lead to a child being judged "presently at risk of sudden death"?
In this episode, we outline the timeline, the people, and the regulatory decisions that shaped GenderGP's trajectory, and we ask whether gaps in the system enabled clinical decisions far outside specialist expertise. What does the record show about responsibility, oversight, and the risks created by rapid private expansion?
Person: J
Person: Helen Webberley
Person: Mike Webberley
Event: High Court ruling stating "presently at risk of sudden death" (May 2024)
Event: Ownership transfer to Harland International (2019)
- In May 2024 a judge in England's High Court wrote that a child known as J was "presently at risk of sudden death."
- GenderGP was founded in 2015 by Helen and Mike Webberley as a UK telemedicine service for transgender youth.
- The clinic operated on a "stage not age" philosophy, assessing readiness for hormones by puberty stage rather than chronological age.
- The General Medical Council placed Helen Webberley under interim suspension in May 2017; Mike Webberley was placed under interim suspension in May 2019.
- In 2019 ownership of GenderGP transferred to Harland International, a company registered in Hong Kong, while the clinic continued prescribing hormones to minors.
To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.
© 2026 OBOMEDIA. All rights reserved.
This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません